LifeStance Health Group, Inc. Share Price

Equities

LFST

US53228F1012

Healthcare Facilities & Services

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
6.2 USD +0.65% Intraday chart for LifeStance Health Group, Inc. +8.58% -20.82%
Sales 2024 * 1.22B 102B Sales 2025 * 1.38B 115B Capitalization 2.37B 198B
Net income 2024 * -104M -8.67B Net income 2025 * -76M -6.34B EV / Sales 2024 * 2.1 x
Net Debt 2024 * 186M 15.49B Net Debt 2025 * 117M 9.79B EV / Sales 2025 * 1.8 x
P/E ratio 2024 *
-21.8 x
P/E ratio 2025 *
-28.6 x
Employees 9,325
Yield 2024 *
-
Yield 2025 *
-
Free-Float 26.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.65%
1 week+8.58%
Current month+0.49%
1 month+0.49%
3 months-3.58%
6 months+10.12%
Current year-20.82%
More quotes
1 week
5.81
Extreme 5.81
6.25
1 month
5.62
Extreme 5.615
6.47
Current year
4.74
Extreme 4.735
9.20
1 year
4.74
Extreme 4.735
9.59
3 years
4.22
Extreme 4.22
29.81
5 years
4.22
Extreme 4.22
29.81
10 years
4.22
Extreme 4.22
29.81
More quotes
Managers TitleAgeSince
Founder 39 01/17/01
Chief Executive Officer 65 07/22/07
Director of Finance/CFO 55 10/22/10
Members of the board TitleAgeSince
Chief Executive Officer 65 07/22/07
Director/Board Member 50 01/17/01
Director/Board Member 51 01/17/01
More insiders
Date Price Change Volume
26/24/26 6.2 +0.65% 647,258
25/24/25 6.16 -0.16% 864,655
24/24/24 6.17 +0.98% 1,397,448
23/24/23 6.11 +4.09% 1,893,754
22/24/22 5.87 +2.80% 1,071,433

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
6.2 USD
Average target price
8.786 USD
Spread / Average Target
+41.70%
Consensus